{"m_szDocID":"117828","m_szDocTitle":"Microsized Curcumin Compositions (Lsu Health Sciences Center Shreveport)","m_szYear":"2016","m_szDocSumamry":"Toggle navigation Popular Companies TOP 200 Companies Full Directory Amazon Apple Boeing Ebay Facebook Google IBM Microsoft Nike Qualcomm Samsung Sony MIT UC Popular Topics Augmented Reality Beverage Brain Cancer Cloud Computing Electric Vehicle Gesture Golf Graphene Machine Learning Medical Device Robots Solar Social Network Virtual Reality Wearables Login / Register TOP 200 Companies filing patents this week Free Services   MONITOR KEYWORDS Enter keywords & we'll notify you when a new patent matches your request (weekly update). ORGANIZER Save & organize patents so you can view them later. A","m_szDocBody":"toggle navigation popular company top company full directory amazon apple boeing ebay ibm microsoft nike qualcomm samsung sony mit popular topic augmented reality beverage brain cancer cloud computing electric vehicle gesture golf graphene machine learning medical device robot solar social network virtual reality wearable top company filing patent week freeservice monitor keyword enter keyword notify patent matches request weekly update organiser save organise patent later archive month keyword email company directory patent sorted company follow browse patent previous microsized curcumin composition microsized curcumin composition disclosed formulation local delivery therapeutically effective dose curcumin provide sufficient serum level curcumin treat disease head neck disorder upper aerodigestive disorder related term curcumin digest disease effective dose serum therapeutical browse recent lsu health science centre shreveport patent uspto applicaton inventor cherieann nathan patent description claim data uspto patent application microsized curcumin composition statement government support presently disclosed subject matter made united state government support grant #rca awarded national cancer institute accordingly united state government right presently disclosed subject matter crossreference related application application claim benefit usc provisional application converted application ser filed sep incorporated reference background field invention invention relate therapeutic formulation preparation method treating disease disorder state art annually head neck squamous cell cancer hnscc patient death case worldwide advance treatment survival rate improved significantly decade treatment failure early stage disease result primary tumour spt and advanced stage disease development local recurrence metastasis resulting morbidity mortality result field cancerization probability spt occur constant risk year initial treatment year year survival rate patient chemopreventive agent delay arrest reverse carcinogenesis entire mucosa exposed carcinogen tobacco alcohol undergone atypical change moderate severe dysplasia oral cavity larynx welldefined risk progressing invasive cancer patient hence chemoprevention agent adjuvant therapy prevent recurrence hnscc occur year agent appear promising potential prevention tumour progression curcumin curcumin proposed chemoprevention agent poor bioavailability problem dysphagia difficulty swallowing occur cancer resection mucositis xerostomia chemotherapy radiation therapy making difficult patient swallow large pill case curcumin large dose needed overcome poor bioavailability lesson learned previous study agent preclinical study shown compound chemopreventive property made clinical trial retinoid beststudied class randomised retinoid trial conducted date premalignant oral lesion shown prevent recurrence spt trial showed significant response rate dose related mucocutaneous toxicity major adverse effect encountered trial relapse rate noted prolonged maintenance therapy trial retinoid hnscc patient spt significantly reduced change survival believed due toxicityrelated drop retinoid arm highlighting importance investigating dietary supplement curcumin efficacy improvement toxicity nonsteroidal antiinflammatory drug nsaid widely investigated chemoprevention agent due antiangiogenic property agent rodent model large study chemopreventive effect cox inhibitor celebrex halted increased risk cardiovascular event toxicity patient cox inhibitor vioxx removed market cox inhibitor celebrex markedly limited focus induce tumour cell apoptosis compensating cox function increase efficacy minimise toxicity safer agent long term chemopreventive agent curcumin attracted attention due antitumor activity negligible toxicity human animal curcumin current problem natural product isolated turmeric curcumin implicated powerful therapeutic variety human cancer ability induce apoptosis undergoing clinical trial colon skin pancreatic hematologic cancer effect hnscc limited vivo benefit due low gastrointestinal absorption study shown increased bioavailability curcumin administered conjunction black pepper extract piperine rat human human single dose efficacy remain controversial commercially combination curcumin piperine curcumin complex sabinsa corp piscataway evaluated phase iii trial metastatic colon cancer doselimiting toxicity reported human clinical trial curcumin pharmacologically active level curcumin achieved colorectal tissue patient taking oral curcumin due prolonged local contact data lacking pharmacologically active concentration curcumin achieved tissue directly exposed local application pharmacokinetic study curcumin low bioavailability curcumin oral administration significant controversy bioperine role improving bioavailability curcumin toxic side effect inevitable chemotherapy regimen unacceptable chemoprevention daily dosing curcumin gramme daily month demonstrated doselimiting toxicity higher dosing prohibited due bulkiness pill pose problem head neck cancer patient postsurgery radiation swallowing impaired curcumin poor bioavailability concentration required efficacy limited use desirability improve bioavailability serum level curcumin patient head neck cancer patient summary top invention invention directed part discovery microsized particle such microgranule curcumin significantly enhance transmucosal delivery curcumin oral cavity mouth improvement contraindicated micronizing poorly soluble drug increase water solubility opposed increase mucosal delivery limited theory believed large amount curcumin delivery vehicle gradual release curcumin carrier mucosal membrane increase systemic concentration curcumin blood stream sufficient systemic serum level curcumin downregulate gene cancer cell proliferation disclosed composition method sufficient amount curcumin contact mucous membrane absorbed oral cavity treatment disease head neck disorder disorder upper aerodigestive track surprisingly discovered delivery curcumin part mucous membrane sufficient amount form microparticulate also called micronsized particle significantly increase serum level curcumin level sufficient downregulate biomarker tumour proliferation fgf gro mipb tnf aspect average curcumin serum level provided micronsized particle provided oral formulation curcumin tablet capsule comprise micronsized particle curcumin aspect average steady state level curcumin aspect provided formulation comprising microsized particle comprising curcumin pharmaceutical composition microsized particle suitable transmucosal delivery pharmaceutical composition comprise pharmaceutically acceptable excipient compatible transmucosal delivery therapeutically effective amount curcumin curcumin dosage form composition amount aspect microsized particle pharmaceutical composition microsized particle comprise nicotine aspect microsized particle pharmaceutical composition microsized particle acidic aspect microsized particle pharmaceutical composition microsized particle comprise pharmaceutically acceptable acid aspect composition comprise microsized particle comprising curcumin aspect microsized particle size micron micron micron micron aspect composition comprise microsized particle comprising curcumin aspect microsized particle number average size micron micron micron micron aspect microsized particle administered directed mucous membrane sublingual area month aspect microsized particle formulated form chewing gum capsule such dissolvable capsule conveniently administered transmucosal aspect microsized particle packaged pouches capsule opened administration delivering curcumin optionally therapeutic agent locally systemic bioavailability therapeutic concentration achieved aspect invention addresse problem providing solid formulation method delivery curcumin therapeutic agent absorption oral mucosa accordance embodiment invention solid formulation form excipient facilitate mucosal delivery curcumin embodiment excipient provided lozenge chewing gum embodiment provided solid formulation curcumin agent phytochemical vitamin mineral aspect provided method maintaining therapeutic blood serum concentration curcumin patient method comprise transmucosally administering therapeutic amount microsized curcumin composition thereof patient patient maintain serum concentration curcumin hour aspect method comprise administering microsized curcumin composition thereof patient frequency period time maintain serum concentration curcumin period hour initial administration aspect provided method treating cancer patient thereof method comprise transmucosally administering therapeutic amount microsized curcumin composition thereof patient patient maintain serum concentration curcumin hour aspect provided method preventing formation cancerin patient susceptible formation cancer method comprise transmucosally administering therapeutic amount microsized curcumin composition thereof patient patient maintain serum concentration curcumin hour embodiment invention claim follow description drawing top fig represent plot growth inhibition hncc cell vivo treatment curcumin complex fig western blot tissue sample sleep apnea noncancer patient cancer patient tumour histologically tumorfree margin probed antibody phospoakt phosphomtor fig represent curcumin effect nfb pathway hnscc cell line vitro vivo fig represent manufacturing flow chart embodiment curcumin microparticulate curcuminccomplex fig represent serum level curcumin head neck cancer patient healthy volunteer consumed microgranular formulation curcumin volunteer daily cancer patient serum sample collected hour initial dose cancer patient only week daily curcumin consumption shown fig analysis fgf expression ihc representative matched tumour sample collected pre note strong positive dark staining consumption curcumin daily week post shown fig show avg serum curcumin meanse male female healthy volunteer significant level pvalue detailed description top invention aspect provided solid oral formulation comprising therapeutically effective amount curcumin pharmaceutically acceptable carrier oral mucosal delivery curcumin noted that specification appended claim singular form include plural referent context dictate otherwise thus example reference pharmaceutically acceptable carrier include mixture pharmaceutically acceptable carrier like optional optionally mean subsequently event circumstance occur description include instance event circumstance occur instance not example phrase optionally cleaning step mean cleaning step performed term comprising intended composition method include recited element excluding other consisting essentially define composition method excluding element essential significance combination example composition consisting essentially element defined exclude element materially affect basic characteristic claimed invention consisting excluding trace amount ingredient substantial method step recited embodiment defined transition term scope invention term numerical vary reasonable range stated value aspect unit dose curcumin composition suitable transmucosal delivery composition comprise microsized curcumin microsized curcumin unit dose amount aspect unit dose composition comprise curcumin range number end point included aspect unit dose delivered once time daily aspect provided pharmaceutical composition unit dose suitable transmucosal delivery composition comprise pharmaceutically acceptable excipient compatible transmucosal delivery therapeutically effective amount curcumin curcumin dosage form composition amount aspect composition comprise curcumin range number end point included aspect unit dose delivered once time daily aspect composition comprise microsized particle comprising curcumin aspect microsized particle size micron micron micron micron micron micron micron micron micron micron micron micron aspect microsized particle size micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron micron range number end point included aspect microgranular curcumin refer microsized particle coarse surface greater surface area nongranular material due coarse surface aspect amount curcumin microsized particle microsized particle range number end point included aspect amount curcumin microsized particle microsized particle aspect amount curcumin microsized particle microsized particle aspect composition comprise bisdemethoxycurcumin demethoxycurcumin total amount curcumin bisdemethoxycurcumin demethoxycurcumin referred total curcuminoid aspect bisdemethoxycurcumin composition amount total curcuminoid aspect demethoxycurcumin composition amount total curcuminoid aspect curcumin composition amount total curcuminoid aspect amount total curcuminoid microsized particle microsized particle range number end point included aspect total curcuminoid microsized particle microsized particle aspect total curcuminoid microsized particle microsized particle aspect microsized particle pharmaceutical composition microsized particle comprise buffer pharmaceutically acceptable acid reduce mucous membrane aspect microsized particle pharmaceutical composition microsized particle acidic range number end point inclusive aspect microsized particle pharmaceutical composition microsized particle comprise pharmaceutically acceptable acid dichloroacetic acid oxoglutaric acid aminosalicylic acid acetic acid adipic acid ascorbic acid aspartic acid benzenesulfonic acid camphoric acid camphorsulfonic acid capric acid decanoic acid caproic acid hexanoic acid caprylic acid octanoic acid carbonic acid cinnamic acid citric acid cyclamic acid galactaric acid gentisic acid glucoheptonic acid gluconic acid glucuronic acid glutamic acid glutaric acid glycerophosphoric acid glycolic acid hippuric acid isobutyric acid lactic acid lactobionic acid lauric acid maleic acid malic acid malonic acid mandelic acid nicotinic acid oleic acid oxalic acid palmitic acid pamoic acid proprionic acid pyroglutamic acid salicylic acid sebacic acid stearic acid tartaric acid undecylenic acid limited theory contemplated weak acidic improve curcumin absorption aspect microsized curcumin particle composition thereof comprise pharmaceutically acceptable carrier aspect microsized curcumin particle surprisingly provide improved transmucosal absorption bioavailability curcumin significant chewing swallowing patient compared composition gum tablet capsule difficult patient cancer premalignant lesion month aspect microsized curcumin particle sterile method sterilisation art refluxing curcumin solvent ethanol suitable oral solid formulation include form chewing gum lozenge candy administration curcumin oral mucosa solid formulation pharmaceutically acceptable carrier relevant form carrier skill art formulation chewed sucked buccal cavity administered sublingually solid formulation number shape nonlimiting example include flat stick formulation circular octagonal biconvex shape administration curcumin microparticulate gum formulation heightened exposure drug added quality gum make palatable dosage extended dose time aspect amount total curcuminoid curcumin gum gum range number end point included aspect total curcuminoid curcumin gum gum aspect total curcuminoid curcumin gum gum pharmaceutical acceptable carrier include ingredient buffer flavouring aroma agent sweetener colourant preservative antioxidant softener thickening agent emulsifier glidant lubricant mixture thereof buffer aid absorption curcumin oral mucosa preferred buffer capable decreasing saliva administration suitable buffer include sodium carbonate sodium bicarbonate calcium carbonate potassium carbonate potassium bicarbonate sodium potassium dibasic sodium potassium tribasic potassium phosphate dibasic potassium phosphate tribasic magnesium hydroxide potassium hydroxide aluminium hydroxide mixture thereof aspect buffer comprise solid formulation flavorant aroma agent include essential oil natural synthetic compound mimic flavour aromas fruit flavorant include lemon orange lime spearmint wintergreen chocolate cinnamon vanilla coffee menthol taste suitable flavorant amount include formulation weight flavorant sweetener natural artificial sweetener example sweetener include sucrose fructose mannitol sorbitol xylitol powdered sugar granulated sugar molasse saccharin acesulfame aspartame nutrasweet splenda mixture thereof aspect sweetener comprise weight solid formulation aspect sweetener comprise weight formulation suitable colourant include dye pigment natural food colour approved food additive aspect colourant comprise weight formulation solid formulation oil lubricant aid preparation formulation prevent sticking equipment mould aspect oil comprise weight formulation curcumin formulation prepared synthetically isolated natural source embodiment provided chewing gum optionally coating layer gum comprise gum base corn syrup citric acid glycerin therapeutically effective amount curcumin optionally sweetener processe preparing gum coating art coating aid enhancing taste product stability storage suitable coating include sweetened candy coating gum base nonnutritive masticatory substance inert insoluble nonnutritive product support edible soluble portion chewing gum sweetener glucose flavour etc general description gum base chewing gum product world recognised food chemical codex national legislation gum base produced blend raw material categorised classe elastomer resin act binder softener plasticizer render elastomer soft ensure blending gum base filler contribute texture antioxidant prevent oxidation gum base flavour shelf life suitable gum base include natural synthetic gum base synthetic gum base mixture elastomer plasticizer filler softener emulsifier waxe example gum base include agar alginate arabic gum carob gum carrageenan ghatti gum guar gum karaya gum pectin tragacanth gum locust beam gum gellan gum xantham gum gum base comprise weight chewing gum excluding weight coating layer embodiment amount curcumin piece gum aspect amount curcumin embodiment gum base sufficient maintain curcumin gum matrix delivery embodiment solid formulation sweetener selected consisting powdered sugar granulated sugar molasse aspartame nutrasweet splenda aspect solid formulation sweetener embodiment provided chewing gum corn syrup piece chewing gum aspect chewing gum corn syrup embodiment provided chewing gum citric acid aspect chewing gum citric acid embodiment provided chewing gum glycerin aspect chewing gum glycerin aspect composition comprise nanoparticle particle size aspect composition comprise polymeric nanoparticle hydrophobic core hydrophilic shell polymeric nanoparticle medicament trapped hydrophobic core nanoparticle aspect composition comprise polymeric nanoparticle average diameter equal greater diameter aspect composition comprise nanoparticle pegylated outer surface aspect composition comprise nanoparticle made anisoproylacrylamide watersoluble vinyl compound make particle shell hydrophilic waterinsoluble vinyl derivative make particle core hydrophobic acrylic acid method preparation embodiment provided method folding therapy chewing gum chewing slowly released oral cavity therapeutic solubilized wet levigated folded single piece gum foregoing method phytochemical including limited egcg green tea polyphenol epigallocatechingallate resveratrol piperine genistein lycopene lutein perillyl alcohol alphacarotene saponin terpeneol terpene limonoid hesperetin silymarin tangeretin ferulic acid sulforaphene capsaicin folded chewing gum nutritional substance including limited vitamin vitamin vitamin vitamin vitamin mineral iron calcium potassium nutritional supplement aspect curcumin curcuminoid phytochemical nutritional supplement folded chewing gum aspect amount phytochemical aspect invention phytochemical including limited curcumin egcg resveratrol piperine genistein lycopene lutein perillyl alcohol alphacarotene saponin terpeneol terpene limonoid hesperetin silymarin tangeretin ferulic acid sulforaphene capsaicin delivered oral cavity form spray paste nutritional substance including limited vitamin vitamin vitamin vitamin vitamin mineral iron calcium potassium nutritional supplement foregoing method paste consist maximally soluble amount phytochemical nutritional substance make previous download full full patent advertise freshpatentscom rate info monitor keyword tracking patent relating microsized curcumin composition patent application ### browse recent lsu health science centre shreveport patent keyword monitor work free service freshpatent take second fill keyword monitored week receive patent application related keyword start now receive info patent app microsized curcumin composition areas interest ### previous patent application microscope system surgery patent application midinfrared scanning system industry class viewing microsized curcumin composition patent info result second interesting freshpatentscom category medical surgery surgery surgery drug drug prosthesis dentistry ### data source patent application published public domain united state patent trademark office uspto information published purpose only freshpatent affiliated uspto assignee company inventor law firm assignee patent application document image trademark respective freshpatent responsible accuracy validity content public document patent application filing complete provided however case presented sampling full patent application display purpose freshpatentscom previous patent info application publish date document file date uspto class uspto classe international class drawing curcumin digest disease effective dose serum therapeutical follow lsu health science centre shreveport browse recent lsu health science centre shreveport patent browse patent previous","m_szGeo1":"Canada","m_szSourceType":"source_general","m_szSrcUrl":"http://www.freshpatents.com/-dt20160331ptan20160089343.php","m_Places":["Enter","United States","United States C.","Orange"],"m_People":["Ann Nathan"],"m_Companies":["Amazon","Apple","Boeing","Ebay","Facebook","Google","Ibm","Microsoft","Nike","Qualcomm","Samsung","Sony","Uc","Twitter","Lsu Health Sciences Center Shreveport","Uspto","United States Government","National Cancer Institute","Sabinsa Corp.","Oral Administration","Buffer","Matrix","Shell","United States Patent And Trademark Office"],"m_BiGrams":["microsized particle","chewing gum","aspect microsized","microsized curcumin","composition comprise","curcumin composition","amount curcumin","solid formulation","gum base","pharmaceutically acceptable","aspect composition","total curcuminoid","pharmaceutical composition","composition microsized","cancer patient","level curcumin","concentration curcumin","range number","number end","end point","aspect amount","serum level","head neck","transmucosal delivery","aspect provided","particle pharmaceutical","acceptable carrier","unit dose","point included","included aspect","particle microsized","therapeutically effective","oral cavity","delivery curcumin","curcumin aspect","comprise pharmaceutically","composition amount","serum concentration","composition thereof","amount total","comprise weight","lsu health","health science","science centre","centre shreveport","bioavailability curcumin","curcumin oral","mucous membrane","formulation curcumin","particle comprising","comprising curcumin","effective amount","particle comprise","comprise microsized","particle size","size micron","provided method","thereof patient","maintain serum","aspect unit","curcumin microsized","particle aspect","curcuminoid aspect","aspect total","citric acid","curcumin gum","provided chewing","including limited","delivery therapeutically","effective dose","browse recent","recent lsu","shreveport patent","united state","chemoprevention agent","poor bioavailability","clinical trial","cox inhibitor","neck cancer","mucosal delivery","composition method","micronsized particle","suitable transmucosal","amount aspect","acceptable acid","oral mucosa","vitamin mineral","transmucosally administering","administering therapeutic","therapeutic amount","amount microsized","curcumin hour","curcuminoid microsized","curcumin particle","curcuminoid curcumin","mixture thereof","weight formulation","corn syrup","gum aspect","aspect chewing"],"m_TriGrams":["aspect microsized particle","microsized curcumin composition","aspect composition comprise","pharmaceutical composition microsized","composition microsized particle","range number end","number end point","microsized particle pharmaceutical","particle pharmaceutical composition","end point included","point included aspect","serum level curcumin","comprise pharmaceutically acceptable","serum concentration curcumin","pharmaceutically acceptable carrier","amount total curcuminoid","lsu health science","health science centre","science centre shreveport","microsized particle comprising","particle comprising curcumin","therapeutically effective amount","effective amount curcumin","microsized particle comprise","composition comprise microsized","curcumin composition thereof","composition thereof patient","maintain serum concentration","aspect unit dose","aspect amount curcumin","total curcuminoid aspect","aspect total curcuminoid","provided chewing gum","delivery therapeutically effective","browse recent lsu","recent lsu health","centre shreveport patent","head neck cancer","neck cancer patient","suitable transmucosal delivery","pharmaceutically acceptable acid","comprise microsized particle","comprising curcumin aspect","curcumin aspect microsized","microsized particle size","particle size micron","aspect provided method","method comprise transmucosally","comprise transmucosally administering","transmucosally administering therapeutic","administering therapeutic amount","therapeutic amount microsized","amount microsized curcumin","concentration curcumin hour","amount curcumin microsized","curcumin microsized particle","composition amount total","total curcuminoid microsized","curcuminoid microsized particle","aspect microsized curcumin","microsized curcumin particle","total curcuminoid curcumin","curcuminoid curcumin gum","comprise weight formulation","aspect chewing gum","composition comprise nanoparticle"],"m_SocialTags":[],"m_Topics":[],"m_Industry":[],"m_Technology":[],"m_BiCnt":[38,17,16,15,14,12,12,11,11,10,10,10,9,8,8,7,7,7,7,7,7,6,6,6,6,6,6,6,6,6,6,5,5,5,5,5,5,5,5,5,5,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3],"m_TriCnt":[13,10,10,7,7,7,7,6,6,6,6,5,5,5,5,5,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3],"m_iDocBodyWordCnt":2599}
